Baird Financial Group, Inc. Bristol Myers Squibb CO Transaction History

Baird Financial Group, Inc.

$47.6 Billion
Q2 2024

A detailed history of Baird Financial Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Baird Financial Group, Inc. holds 574,250 shares of BMY stock, worth $30.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

574,250

Previous 846,654 32.17%

Holding current value

$30.5 Million

Previous $45.9 Million 48.06%

% of portfolio

0.05%

Previous 0.1%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$40.25 - $52.99 $11 Million - $14.4 Million	-272,404 Reduced 32.17%	574,250 $23.8 Million
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $2.76 Million - $3.13 Million	-57,512 Reduced 6.36%	846,654 $45.9 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $7.73 Million - $9.22 Million	-159,405 Reduced 14.99%	904,166 $46.4 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $729,298 - $815,468	12,598 Added 1.2%	1,063,571 $61.7 Million
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $2.56 Million - $2.84 Million	-40,112 Reduced 3.68%	1,050,973 $67.2 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $280,581 - $318,243	-4,270 Reduced 0.39%	1,091,085 $75.6 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $3 - $1,921	-25 Reduced -0.0%	1,043,760 $74.2 Million
Q2 2022 Aug 08, 2022	SELL	$72.62 - $79.98 $16.8 Million - $18.5 Million	-231,590 Reduced 18.16%	1,043,785 $80.4 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $3.58 Million - $4.29 Million	-58,254 Reduced 4.37%	1,275,375 $93.1 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $10.5 Million - $12.2 Million	-195,439 Reduced 12.78%	1,333,629 $83.2 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $3.85 Million - $4.51 Million	65,023 Added 4.44%	1,529,068 $90.5 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $312,521 - $340,336	5,048 Added 0.35%	1,464,045 $97.8 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $4.63 Million - $5.2 Million	77,949 Added 5.64%	1,458,997 $92.1 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $4.04 Million - $4.58 Million	69,944 Added 5.33%	1,381,048 $85.7 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $8.38 Million - $9.29 Million	145,976 Added 12.53%	1,311,104 $79 Million
Q2 2020 Oct 22, 2020	BUY	$54.82 - $64.09 $6.11 Million - $7.15 Million	111,541 Added 10.59%	1,165,128 $67.7 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $4.1 Million - $4.79 Million	-74,757 Reduced 6.63%	1,053,587 $65.6 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $3.12 Million - $4.53 Million	67,240 Added 6.34%	1,128,344 $62.9 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $5.41 Million - $7.06 Million	109,960 Added 11.56%	1,061,104 $68.1 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $4.65 Million - $5.51 Million	-108,636 Reduced 10.25%	951,144 $48.2 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $16.4 Million - $18.1 Million	367,528 Added 53.09%	1,059,780 $48.1 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $4.7 Million - $5.61 Million	104,220 Added 17.72%	692,252 $33 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $2.5 Million - $3.24 Million	-51,245 Reduced 8.02%	588,032 $30.6 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $23,621 - $26,643	428 Added 0.07%	639,277 $39.7 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $1.01 Million - $1.26 Million	19,927 Added 3.22%	638,849 $35.4 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $931,276 - $1.07 Million	15,542 Added 2.58%	618,922 $39.1 Million
Q4 2017 Feb 09, 2018	BUY	$59.94 - $65.35 $612,766 - $668,073	10,223 Added 1.72%	603,380 $37 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $4.28 Million - $4.94 Million	-77,510 Reduced 11.56%	593,157 $37.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	670,667	670,667 $37.4 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Bristol Myers Squibb CO Transaction History